ABOUT JNPMEDI

In 2020, JNPMEDI was founded with the aim of enhancing Korea's globally recognized medical infrastructure by leveraging digital technologies such as blockchain and cloud computing through a cutting-edge medical data platform.


We launched the clinical trial data management solution, Maven Clinical Cloud,
which significantly contributed to the digital transformation of the clinical trial industry.
In 2024, JNPMEDI expanded into professional services, integrating digital technologies into all aspects of our customers' business beyond just clinical trial stages, marking another milestone in its growth.

Now, we are building networks with diverse clients and partners both domestically and internationally, progressing towards becoming a global enterprise.

The Infrastructure
for a Healthier Future


We are building the foundation/infrastructure for a healthier future. 


We create the foundation for a broader world to benefit from the healthier future through digital innovation in life sciences. 

mobile background
Core Values at JNPMEDI Inc. 

CLIENT VALUE FIRST

We continuously provide value through our top-tier solutions and services, enabling our healthcare clients to achieve their goals. 

INTEGRITY AT HEART

We prioritize ethics and integrity in all decision-making processes. We will always take responsibility for our words and actions, no matter the situation. 

SOCIALLY RESPONSIBLE

We are dedicated to improving the healthcare environment through continuous technological development, fulfilling our social responsibility to ensure that all of humanity can benefit. 

More and more clients are partnering with JNPMEDI.

ABOUT JNPMEDI

In 2020, JNPMEDI was founded with the aim of enhancing Korea's globally recognized medical infrastructure 

by leveraging digital technologies such as blockchain and cloud computing
through a cutting-edge medical data platform.


We launched the clinical trial data management solution, Maven Clinical Cloud,
which significantly contributed to the digital transformation of the clinical trial industry.
In 2024, JNPMEDI expanded into professional services, integrating digital technologies into all aspects
of our customers' business beyond just clinical trial stages, marking another milestone in its growth.

Now, we are building networks with diverse clients and partners
both domestically and internationally, progressing towards becoming a global enterprise.


The infrastructure for a healthier future


We are building the foundation/infrastructure for a healthier future. 


We create the foundation for a broader world to benefit from the healthier future 
through digital innovation in life sciences. 


Core Values at JNPMEDI Inc.

CLIENT VALUE FIRST


We continuously provide value through our top-tier solutions and services, enabling our healthcare clients to achieve their goals.

INTEGRITY AT HEART


We prioritize ethics and integrity in all decision-making processes. We will always take responsibility for our words and actions, no matter the situation.

SOCIALLY RESPONSIBLE


We are dedicated to improving the healthcare environment through continuous technological development, fulfilling our social responsibility to ensure that all of humanity can benefit.

240+

Clinical Trial Site

4K+

Solution Usage

30K+

Subject Enrollment

4M+

Data Records
Experts from various fields come together
to support the success of our clients. 

Experts from various fields come together
to support the success of our clients.

• Univ. of Washington B.S. in Applied Physics

• Dunamu Lambda256 Chief Strategy Officer

• Accenture, IBM Management Consultant


• Hanyang University B.S. in Computer Engineering

• Dunamu Lambda256 Development Lead

• eBay Korea, Futurewiz Development Lead 


• Yonsei University B.S. in Chemical Engineering, M.S. in Management Information Systems

• Chong Kun Dang Holdings Business Innovation Team Director

• PwC, Samsung SDS Management Consultant


• Yonsei University Severance Hospital Certified Clinical Pharmacologist 

• Dream CIS, Seoul CRO CEO

• GE Healthcare, Novartis Medical Director


• Yonsei University B.S. in Nursing, Psychology

• Synex MD Clinical Director

• Olive Healthcare Strategy Director


• Seoul National University B.S. in Engineering, M.S. in Dentistry, Ph.D candidate in Medical Informatics 

• Kim & Chang Law Office Healthcare Team Lawyer

• Korean Bar Association Director


• Catholic University M.S. in Medical Statistics

• Seoul CRO Head of DM/IT Department

• DreamCIS DMM


• Ewha Womans University B.S. in Nursing, Seoul National University M.S. in Public Health
• LSK Global PS BD Director
• LSK Global PS DQM Team Leader/DMM


• Catholic Medical University M.S in Biostatistics

• Novotech DM Director

• DreamCIS BS Director, Korea Otsuka DM/BS Manager


• Ewha Womans University B.A. in English Literature, Yonsei University M.S. in Human Resources Development

• IBM APAC Senior Talent Partner

• PwC HR Manager


• Korea University B.S. in Food and Nutrition

•Johnson&Johnson Medical, Ethicon, Terrritory Sales Manager

• RLAP, Assistant Product Manager


• Ohio State University B.S in Biology, University of Michigan M.S in Biostatistics 

• MFDS, Medical Device Devision, Medical Device(Biostat) Reviewer

• Lunit, Cancer Screening Group, Biostatistician


• Dongguk University M.S in Medical Device Industry

• Synex Medical Device R&D Department, Senior Project Manager

• Genewel, RA Team leader


• Sungkyunkwan University M.S in Management of Technology

• KB Securities, Digital Innovation Department, Manager

• Accenture, IBM, Consultant


• Sejong University B.S. in Computer Engineering

• Dunamu Lambda256 Senior Engineer

• ebay Korea Engineer


• Rutgers University B.S. in Biotechnology

• Pfizer, Siemens New York R&D Researcher

• Chong Kun Dang, CHA Biotech Strategy Development